Do you want to read an article? Please log in or register.
Reduced Risk of Lung Cancer Associated with Sodium-Glucose Cotransporter-2 Inhibitors in Patients with COPD and Type 2 Diabetes Mellitus
COPDLung Cancer
Related content
Asthma
Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels
Respir Med
Ararat E, Rastogi D, Martin BC
doi: 10.1016/j.rmed.2025.108403
Lung Cancer
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)
Lung Cancer
Borghetti P, D'Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U, Collaborators
doi: 10.1016/j.lungcan.2025.108807
RECOMMENDED
Lung Cancer
Cumulative Incidence and Type-Specific Risk Factors of Pneumonitis After Definitive Chemoradiotherapy With or Without Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Sun J, Dong X, Fu Z, Han S, Liu Y, Shi A, Yu H, Zhao Y, Deng W, Jiang L, Yang D, Chang X, Long L, Yu J, Teng Y, Yu R, Wang W
doi: 10.1016/j.cllc.2025.11.020
Lung Cancer
Associations between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis
Chest
Swami N, Hong JH, Kho S, Kang HM, Chun-Chia Lin L, Ni SC, Florez N, Lan Q, Rothman N, Dee EC, Gomez SL, Cheng I
doi: 10.1016/j.chest.2025.12.034
Lung Cancer
Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study
Lung Cancer
Mokkenstorm K, van Beusekom S, Breukhoven C, Veldman A, Pustjens S, Dijkstra N, Bos-Gerkema M, Kunst P, Smit A, Geerse O, Santeon VBHC lung cancer group
doi: 10.1016/j.lungcan.2026.109551
RECOMMENDED
Lung Cancer
Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Liu G, Abrahami D, Ramachandran P, Messina R, Rifi N, Yang H, Chai X, Li B, Ramaswamy K, Iyengar P, Pennell NA, Shaw AT
doi: 10.1016/j.lungcan.2025.108858
Interstitial Lung DiseaseLung Cancer
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study
Thorax
Karayama M, Miyashita K, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Suda T
doi: 10.1136/thorax-2025-223430
Lung Cancer
Computer Assisted Nodule Analysis and Risk Yield Outcomes May be Associated with Recurrence after Stereotactic Body Radiation Therapy in Clinical Stage I Non-Small-Cell Lung Cancer
Clin Lung Cancer
Pham D, Thakur N, Park JA, Nie W, Correa M, Wang H, Subramanian M, Weyant M, Johnson CB, Suzuki K
doi: 10.1016/j.cllc.2025.10.008
Lung Cancer
Real-world evaluation of the christie symptom inventory-lung cancer (CSI-lung) electronic patient-reported outcome measure: validity, reliability, responsiveness, and patient experiences
Lung Cancer
Nuamek T, Liao K, Ward A, Devaraj RL, Price J, Noon K, Taylor S, Faivre-Finn C, Yorke J
doi: 10.1016/j.lungcan.2026.109564